NIS

0.00%

1.6¢ nickelsearch limited

Ann: Allkem Technical Collaboration on Lithium Potential, page-98

First 98 Last

Share
Profile

Follow
DD72

4,077 Posts.

504

09/11/23

21:19

Post #: 70819502
Share

Originally posted by MahoganyPark: ↑

Is this an explanation.
.
.
A day on from an uneventful AGM the real business is afoot for Allkem (ASX:AKE) as it moves to finalise the merger with America’s Livent by early 2024. The companies are looking to combine in a deal that would create the world’s third biggest player by lithium volumes, at least once all of their myriad growth options are brought to market by later this decade.If successful, the merger would see Allkem’s ASX and TSX shares delisted by January 5, a day after the new company’s shares begin trading on the New York Stock Exchange. Its CDIs will be traded on the ASX.Allkem has received the vote of support it needed from independent expert Kroll Australia, releasing a scheme booklet for the December 19 meeting containing a report from Kroll that deemed the offer ‘fair’.They value Allkem at an equity value of between $12.76-15.41, well above the $9.22 trading value of the stock today, and placed the combined equity value of the group at between $9.79 and $11.43 billion.That’s well below the roughly $16b value trumpeted when it was originally announced roughly six months ago, but also comes after Allkem and Livent shares tumbled 26.1% and 38.2% lower over the period as lithium prices have dropped significantly.Allkem shareholders will emerge with 56.1% of the merged entity once the deal is done, while Livent – spawned from within lithium battery pioneer FMC Lithium – will hold 43.9%.Kroll thinks Allkem and Livent, to become a new lithium player known as Arcadium Lithium, will see $603-654m of synergies on a discounted cash flow basis, along with $200m in one times capex savings by being able to share infrastructure across its Sal de Vida and Salar de Hombre Muerto assets in Argentina and the James Bay and Nemaska Lithium deposits in Quebec.At Wednesday’s AGM at Perth’s Crown Towers, where shareholders will reconvene in a little over a month, Allkem’s Peter Coleman – who will become chairman of the merged vehicle –

Expand

Are you suggesting AKE could possibly take over NIS before finalising merger with Livent?

Sorry, I don't quite get the context of the post.

Regards

DD

NIS Price at posting: 9.8¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 57 more messages in this thread...

First 98 Last

Add NIS (ASX) to my watchlist

(20min delay)
Last 1.6¢		Change 0.000(0.00%)		Mkt cap ! $4.011M

Open	High	Low	Value	Volume
1.6¢	1.6¢	1.6¢	$39.91K	2.494M

Buyers (Bids)

No.	Vol.	Price($)
11	4699999	1.5¢

Sellers (Offers)

Price($)	Vol.	No.
1.6¢	87806	1

View Market Depth

No.	Vol.	Price($)
11	4699999	0.015
7	1061680	0.014
3	1830000	0.013
4	749995	0.012
5	862725	0.011

Price($)	Vol.	No.
0.016	87806	1
0.017	396130	2
0.018	506063	3
0.019	280000	2
0.020	755555	2

Last trade - 15.53pm 04/10/2024 (20 minute delay)

NIS (ASX) Chart

Ann: Allkem Technical Collaboration on Lithium Potential, page-98

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Allkem Technical Collaboration on Lithium Potential, page-98

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News